GLP-1 RAs and Dietary Intake and Body Composition

November 12, 2026 updated by: Angela Hillman, Ohio University

Longitudinal Effects of GLP-1 Receptor Agonists on Dietary Intake and Body Composition

To assess longitudinal changes in dietary intake, body composition and metabolism with GLP-1 RA use.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Athens, Ohio, United States, 45701
        • Recruiting
        • Exercise Physiology Lab
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

People taking GLP-1 RA medications

Description

Inclusion Criteria:

  • Currently taking GLP-1 medications and have been taking them for less than a month
  • between the ages of 18-75 years

Exclusion Criteria:

  • Not between the ages of 18-75 years
  • Not currently using GLP-1 medications
  • Have been using GLP-1 medications for 1 month or longer
  • Currently pregnant
  • Currently nursing
  • Bariatric surgery in the last 3 months
  • Have an implanted cardiac device, such as a pacemaker or defibrillator
  • Not willing to have a DEXA (full body x-ray) at the start and end of the 12 week study period
  • Not willing to have a bioelectrical impedance body composition scan at the start and every 2 weeks during the 12 week study period
  • Not willing to have your resting metabolism measured at the start and end of the 12 week study period
  • Not willing to track your diet at the beginning and end of the study
  • Not willing to complete surveys assessing depression, food noise and disordered eating

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: PROSPECTIVE

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in body mass
Time Frame: 12 weeks

change in body weight measured in kg using BIA and DEXA

12 weeks
change in skeletal muscle mass
Time Frame: 12 weeks

change in skeletal muscle mass measured in kg using BIA and DEXA

12 weeks
change in body fat mass
Time Frame: 12 weeks

change in body fat mass measured in kg using BIA and DEXA

12 weeks
change in resting metabolism
Time Frame: 12 weeks

change in resting metabolic rate in kcals/day as measured via indirect calorimetry

12 weeks
change in substrate utilization rates
Time Frame: 12 weeks

change in resting carbohydrate and fat oxidation rates as measured via indirect calorimetry

12 weeks
change in bone mineral content
Time Frame: 12 weeks

change in bone mineral content measured via DEXA and BIA

12 weeks
change in bone mineral density
Time Frame: 12 weeks

change in bone mineral density measured via DEXA

12 weeks
change in total daily caloric intake
Time Frame: 12 weeks

change in total daily caloric intake measured via 24 hour food diary

12 weeks
change in daily carbohydrate intake
Time Frame: 12 weeks

change in daily carbohydrate intake measured via 24 hour food diary

12 weeks
change in daily fat intake
Time Frame: 12 weeks

change in daily fat intake measured via 24 hour food diary

12 weeks
change in daily protein intake
Time Frame: 12 weeks

change in daily protein intake measured via 24 hour food diary

12 weeks
change in daily mineral intake
Time Frame: 12 weeks

change in daily mineral intake measured via 24 hour food diary

12 weeks
change in daily vitamin intake
Time Frame: 12 weeks

change in daily vitamin intake measured via 24 hour food diary

12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2026

Primary Completion (Estimated)

July 30, 2028

Study Completion (Estimated)

December 31, 2028

Study Registration Dates

First Submitted

November 6, 2026

First Submitted That Met QC Criteria

November 12, 2026

First Posted (Actual)

November 18, 2026

Study Record Updates

Last Update Posted (Actual)

November 18, 2026

Last Update Submitted That Met QC Criteria

November 12, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • IRB-FY26-568

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe